Yuri Deigin

Yuri Deigin is a Co-Founder and CEO at YouthBio Therapeutics Inc., where Yuri leads the development of tissue-specific rejuvenating gene therapies for Alzheimer’s and other age-related diseases.

As a longevity biotech entrepreneur and drug developer, Yuri oversees strategic direction, fundraising, and R&D partnerships to accelerate breakthrough therapies. Yuri's expertise spans management, research, strategy development, operations, and fundraising, particularly within the biotechnology and pharmaceutical industries.

Yuri is also a Member at BrainMind and a Fellow at both the Longevity Biotech Fellowship and Foresight Institute, reflecting a deep engagement with the longevity and biotech ecosystems. Previously, Yuri founded and served as CEO of Youthereum Genetics Inc., focusing on epigenetic rejuvenation therapies, and held CEO roles at Gero Discovery and a stealth biotech startup, leading fundraising and business development for neurology and Alzheimer's therapies.

Prior to these entrepreneurial ventures, Yuri gained significant experience as COO/Managing Director at Pharma Bio LLC, managing clinical development programs and intellectual property strategy for peptide pharmaceuticals, and as VP of Business Development at Peptos Pharma Ltd. Yuri holds an MBA from Columbia University - Columbia Business School and an Hon. B. Sc. in Computer Science and Mathematics from the University of Toronto - University College.

Currently, Yuri is focused on advancing partial reprogramming gene therapies for neurodegenerative conditions and other age-related diseases.

Bio is AI generated & may not be accurate.